About
GenomeDx Biosciences Inc develops genomic-based diagnostic tests aimed at improving the precision of prostate and other cancer diagnoses and enabling better treatment decisions.
Explore GenomeDx Biosciences Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.